Dr. Wyles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
Denver, CO 80204Phone+1 303-602-5148
Education & Training
- University of ColoradoFellowship, Infectious Disease, 2001 - 2004
- University of ColoradoResidency, Internal Medicine, 1998 - 2001
- Northwestern University The Feinberg School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 2005 - Present
- CO State Medical License 2000 - 2025
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C Start of enrollment: 2014 Jan 01
- Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection Start of enrollment: 2019 Nov 15
Publications & Presentations
PubMed
- Hepatitis C-related knowledge and attitude among adults on probation in a large US city.Matthew S Minturn, Kevin F Kamis, David L Wyles, Tracy Scott, Hermione Hurley
Health & Justice. 2024-07-11 - COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) Study.Vikramjit Mukherjee, Radu Postelnicu, Chelsie Parker, Patrick S Rivers, George L Anesi
Critical Care Explorations. 2024-07-01 - 1 citationsDon't Put Off Until Tomorrow What You Can Do Today: Hospital Admissions as an Opportunity to Treat Hepatitis C.Sarah E Rowan, David L Wyles
Clinical Infectious Diseases. 2024-03-20
Press Mentions
- The CDC Says Fully Vaccinated People Don’t Need Masks Anymore. Here’s What That Means in ColoradoMay 14th, 2021
- From Starvation to Overdose, Coronavirus’ Hidden Toll Emerges in Colorado’s Death DataFebruary 17th, 2021
- New DAA for Hepatitis C Effective in Large Majority of Patients with Resistance-Associated SubstitutionsAugust 28th, 2018
- Join now to see all
Grant Support
- Analysis Of HIV/HCV Sexual Transmission Pairs Using Ultra-Deep SequencingNational Institute Of Allergy And Infectious Diseases2012
- An In Vitro System To Study Antiviral Strategies Against Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: